Health

FDA Grants Accelerated Approval to Emrelis (telisotuzumab vedotin-tllv) for Non-Small Cell Lung Cancer With High c-Met Protein Overexpression

DailyTrendDailyTrend
May 15, 2025 - 11:00
 0  0
FDA Grants Accelerated Approval to Emrelis (telisotuzumab vedotin-tllv) for Non-Small Cell Lung Cancer With High c-Met Protein Overexpression
NORTH CHICAGO, Ill., May 14, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that Emrelis (telisotuzumab vedotin-tllv) has been granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Early Alert: Cardiac Cannula Issue from Medtronic

Early Alert: Cardiac Cannula Issue from Medtronic

DailyTrend Aug 16, 2025  0  0

Wegovy Granted Accelerated Approval in the US for the Treatment of MASH

Wegovy Granted Accelerated Approval in the US for the T...

DailyTrend Aug 18, 2025  0  0

A $45 Treatment Can Save a Starving Child. US Aid Cuts Have Frozen the Supply

A $45 Treatment Can Save a Starving Child. US Aid Cuts ...

DailyTrend Aug 16, 2025  0  0

Sport Psychology Tips for Everyday Life

Sport Psychology Tips for Everyday Life

DailyTrend Aug 21, 2025  0  0

FDA Approves Papzimeos (zopapogene imadenovec-drba) for the Treatment of Adults with Recurrent Respiratory Papillomatosis

FDA Approves Papzimeos (zopapogene imadenovec-drba) for...

DailyTrend Aug 18, 2025  0  0

Was Head-Binding an Ancient Way to Get Ahead?

DailyTrend Aug 22, 2025  0  0